Your browser doesn't support javascript.
loading
Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1.
Järveläinen, Harri A; Schmithals, Christian; von Harten, Maike; Kakoschky, Bianca; Vogl, Thomas J; Harris, Stephen; Henson, Claire; Bullen-Clerkson, Gemma; Piiper, Albrecht.
Afiliação
  • Järveläinen HA; Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Schmithals C; Department of Medicine 1, University Hospital Frankfurt, 60590 Frankfurt, Germany.
  • von Harten M; Department of Medicine 1, University Hospital Frankfurt, 60590 Frankfurt, Germany.
  • Kakoschky B; Department of Medicine 1, University Hospital Frankfurt, 60590 Frankfurt, Germany.
  • Vogl TJ; Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, 60590 Frankfurt, Germany.
  • Harris S; Department of Metabolism, Pharmaron UK, Pegasus Way, Crown Business Park, Rushden, Northamptonshire NN10 6ER, UK.
  • Henson C; Department of Metabolism, Pharmaron UK, Pegasus Way, Crown Business Park, Rushden, Northamptonshire NN10 6ER, UK.
  • Bullen-Clerkson G; Department of Metabolism, Pharmaron UK, Pegasus Way, Crown Business Park, Rushden, Northamptonshire NN10 6ER, UK.
  • Piiper A; Department of Medicine 1, University Hospital Frankfurt, 60590 Frankfurt, Germany.
Int J Mol Sci ; 24(6)2023 Mar 16.
Article em En | MEDLINE | ID: mdl-36982773

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article